Eosinopenia in Severe COPD Exacerbation

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DIAGNOSTIC_TEST

Blood eosinophil count

To determine the time it takes for blood eosinophil count to recover to baseline stable state following severe exacerbation of COPD associated with admission eosinopenia and to explore independent factors associated with admission eosinopenia.

Trial Locations (1)

Unknown

RECRUITING

Northumbria Healthcare NHS Foundation Trust, North Shields

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Newcastle University

OTHER

collaborator

Chiesi UK

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Northumbria Healthcare NHS Foundation Trust

OTHER